In this article, we will discuss: 11 Best Marijuana Stocks to Buy Right Now.
On March 23, 2026, Cannabis Business Times reported that bipartisan lawmakers introduced the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act, which aims to provide financial access for cannabis enterprises in the United States. Representatives Troy Carter and Guy Reschenthaler sponsored the bill, which plans to allow state-approved operators to list on major US exchanges and acquire traditional banking services. Carter stated that “access to capital remains one of the biggest barriers,” stressing funding restrictions throughout the sector. The proposal would also provide safe harbor protections to financial institutions that offer loans, insurance, and investment services.
The law operates federal prohibition-related constraints that hinder U.S. operators compared with Canadian peers. Saphira Galoob, CEO of the US Cannabis Roundtable, stated that the law ensures equal chances for American cannabis entrepreneurs, while Boris Jordan described it as a “common-sense step” towards regulatory consistency. The measure also protects financial institutions that provide funds and services. Meanwhile, cannabis is still classified as a Schedule I substance, and President Donald Trump has ordered a prospective reclassification assessment, but no firm timeline has been provided.
With that said, here are the 11 Best Marijuana Stocks to Buy Right Now.
kostrez/Shutterstock.com
Our Methodology
We used screeners to identify Best Marijuana Stocks and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. Finally, we ranked these stocks in ascending order based on the number of hedge fund holders.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
11. Advanced Flower Capital Inc. (NASDAQ:AFCG)
Number of Hedge Fund Holders: 5
On March 4, 2026, Advanced Flower Capital Inc. (NASDAQ:AFCG) reported fourth-quarter 2025 GAAP net income of $0.9 million, or $0.04 per share, with distributable earnings of $(2.8) million, or ($0.12) per share. The corporation announced a full-year GAAP net loss of $(20.7) million, or $0.95 per share, while producing distributable earnings of $8.7 million, or $0.39 per share.
Advanced Flower Capital Inc.’s CEO, Dan Neville, stated that the company focused on disciplined portfolio management and completed its BDC conversion in 2025 by resolving underperforming loans and reallocating capital to lower-middle-market enterprises. On March 2, 2026, the firm declared a cash dividend of $0.05 per common share for the first quarter of 2026, which will be paid on April 15, 2026, to shareholders of record as of March 31, 2026.
Advanced Flower Capital Inc. offers commercial real estate finance services. Its primary business is to originate, structure, underwrite, and manage senior secured loans and other types of loans for established businesses in the cannabis market across states.
10. Organigram Global Inc. (NASDAQ:OGI)
Number of Hedge Fund Holders: 7
On March 5, 2026, Organigram Global Inc. (NASDAQ:OGI) reported the debut of SHRED Shotz, a 65ml single-serve cannabis beverage powered by its FAST nanoemulsion platform with a 15-minute onset. The corporation claims that SHRED generated more than $200 million in retail sales in 2025 and that the new product expands the brand into smaller serving sizes to reach new customers. Vice President Eric Williams stated that the launch incorporates user insights into product innovation while utilizing FAST technology for simplicity and predictability.
Organigram Global Inc. announced first-quarter fiscal 2026 gross revenue of $97.3 million and net revenue of $63.5 million, up 46% and 49% year-over-year, respectively, while producing adjusted EBITDA of $5.3 million, a 273% growth. According to CEO James Yamanaka, the corporation retained Canadian market leadership while improving efficiency, resulting in increased profitability through foreign expansion and operational discipline.
Organigram Global Inc. provides high-quality, indoor-grown cannabis to patients and adult recreational consumers, as well as develops international commercial alliances to expand the company’s global footprint.
9. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)
Number of Hedge Fund Holders: 7
On March 16, 2026, Oppenheimer lowered Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) to Perform from Outperform.
On March 12, 2026, Chicago Atlantic Real Estate Finance, Inc. announced fourth-quarter and full-year 2025 results. The company noted strong portfolio expansion led by new originations. Co-CEO Peter Sack stated that the corporation maintained tight underwriting and shielded over 90% of its portfolio from interest rate reductions using fixed or variable rates with floors. The firm made $51.1 million in new loans and received $40.4 million in repayments from January 1 to March 12, 2026. The firm reported $98.4 million in drawn leverage at the end of the year and roughly $50.0 million in total liquidity as of March 12, 2026. The company expects a dividend payout ratio of 90% to 100% of distributable earnings in 2026. The firm has stated that it may declare a special dividend in the fourth quarter to meet taxable income distribution obligations.
Chicago Atlantic Real Estate Finance, Inc. is a market-leading commercial mortgage REIT that uses extensive real estate, credit, and cannabis experience to originate senior secured loans primarily to state-licensed cannabis businesses in limited-license states across the United States.
8. Canopy Growth Corporation (NASDAQ:CGC)
Number of Hedge Fund Holders: 8
On March 27, 2026, Canaccord started coverage of Canopy Growth Corporation (NASDAQ:CGC) with a Buy rating and a price target of C$2.00. The company is regarded as a major cannabis company that operates in key worldwide adult-use and medical markets while creating and selling a diverse product portfolio. The analyst stated that the company is transitioning from an asset-light, third-party supply strategy to an asset-right, in-house supply model in an attempt to boost its worldwide competitiveness.
On March 16, 2026, Canopy Growth Corporation announced the completion of its acquisition of MTL Cannabis, resulting in one of Canada’s leading medical cannabis firms in terms of sales. The corporation stated that the transaction strengthens its Canadian infrastructure, expands its high-quality flower supply, and supports worldwide growth, notably in Europe. Management anticipates roughly $10 million in run-rate synergies within 18 months while integrating MTL’s promising operations to support a target of positive adjusted EBITDA in fiscal 2027.
Canopy Growth Corporation produces, sells, and distributes cannabis and products derived from cannabinoids for both medical and recreational use. The company operates in the following segments: Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other.
7. WM Technology, Inc. (NASDAQ:MAPS)
Number of Hedge Fund Holders: 9
On March 12, 2026, WM Technology, Inc. (NASDAQ:MAPS) announced fourth-quarter revenue of $43.1 million and full-year revenue of $174.7 million, a decrease from $47.7 million and $184.5 million, respectively. The firm cited pricing pressure and limited client investment in core markets. The corporation reported a $5.0 million net loss in the fourth quarter, down from $3.7 million the previous year, while adjusted EBITDA fell to $10.4 million from $11.9 million. The average monthly paying client dropped to 5,120, and revenue per client fell to $2,804 due to reduced spending and market turnover.
WM Technology, Inc.’s full-year net income was $3.3 million, down from $12.2 million, and adjusted EBITDA fell to $39.8 million from $42.9 million, according to the company. CFO Susan Echard said that the firm started 2026 with solid liquidity, having cash of $62.4 million. CEO Doug Francis stated that the company maintained disciplined operations in the face of industry constraints while forecasting a sequential revenue decline of mid- to high-single digits in the first quarter of 2026.
WM Technology, Inc. runs an online cannabis marketplace. It offers Weedmaps and Weedmaps for Business. It provides cannabis customers with information on cannabis dealers and brands.
6. GrowGeneration Corp. (NASDAQ:GRWG)
Number of Hedge Fund Holders: 11
On March 20, 2026, Alliance Global reduced its price objective for GrowGeneration Corp. (NASDAQ:GRWG) from $1.50 to $1.25 while keeping a Neutral rating, citing fourth-quarter revenue and EBITDA misses during a seasonally sluggish period. The analyst observed that proprietary brands accounted for 36% of Cultivation and Gardening sales. The analyst also said that the management anticipates profitability to improve through higher-margin owned brands and store consolidation, with a break-even EBITDA target in 2026 and a $10 million share repurchase program.
On March 19, 2026, GrowGeneration Corp. announced fourth-quarter net sales of $37.8 million, up 1.0%, while expanding gross margin to 24.1% and lowering operating expenses by 44.4%, resulting in a net loss of $7.4 million and an adjusted EBITDA loss of $2.0 million. The corporation reported full-year net sales of $161.7 million, a net loss of $24.0 million, and an improved adjusted EBITDA loss of $6.0 million, while ending with $46.1 million in cash and no debt.
GrowGeneration Corp. is involved in the development, marketing, retail, and distribution of hydroponic products and services. It operates in three segments: Cultivating and gardening, storage solutions, and corporate.
5. Tilray Brands, Inc. (NASDAQ:TLRY)
Number of Hedge Fund Holders: 12
On March 26, 2026, Tilray Brands, Inc. (NASDAQ:TLRY) reported a partnership with The Magnum Ice Cream Company to sell Popsicle-branded ready-to-drink alcoholic beverages in the United States. Tilray initially introduced Popsicle Hard beverages with 5% ABV, offering non-carbonated Hard Cherry, Hard Orange, and Hard Grape flavors in variety packs. The corporation plans to launch a statewide release in March at major retailers, including Walmart, Kroger, and Safeway, followed by a Popsicle Hard Firecracker edition in May 2026. According to Prinz Pinakatt, Tilray’s Chief Growth Officer, the agreement broadens the company’s beverage offering and uses Popsicle’s brand familiarity to reach adult consumers.
On March 19, 2026, Tilray Brands, Inc.’s division, Tilray Medical, reported its largest medical cannabis portfolio expansion in Australia, expanding product availability to meet surging demand in the regulated market. The company plans to expand its local offerings while selling EU-GMP-certified medicines through established prescribers, pharmacies, and clinical distribution channels. Tilray Brands’ President of International, Rajnish Ohri, stated that Australia is a major market in the firm’s global growth plan.
Tilray Brands, Inc. is a consumer packaged goods firm specializing in medical cannabis research and the cultivation, processing, and global distribution of cannabis products. It operates in the following segments: cannabis, distribution, beverage, and wellness.
4. SNDL Inc. (NASDAQ:SNDL)
Number of Hedge Fund Holders: 15
On March 12, 2026, SNDL Inc. (NASDAQ:SNDL) announced fourth-quarter and full-year 2025 results, with net revenue of $252.5 million for the quarter and $946.4 million for the year, representing a 2.0% quarterly reduction and 2.8% annual growth. The corporation reported a record gross profit of $70.2 million in the fourth quarter and $258.6 million for the year, while gross margins increased to 27.8% and 27.3%, respectively. SNDL Inc. produced $11.8 million in operating income in Q4 and posted a $6.3 million loss for the year, with adjusted operating income breaking even at $0.1 million.
The firm achieved positive cash flow of $11.7 million in Q4 and $33.9 million for the year, with free cash flow of $10.2 million and $18.0 million, more than doubling from the previous year. CEO Zach George said that SNDL Inc. accomplished record income statement and cash flow performance despite pursuing restructuring, retail development, and share buybacks, repurchasing 4.3 million shares since December 2025.
SNDL Inc. is a licensed producer that makes small-batch cannabis in advanced indoor facilities. It operates in four segments: liquor retail, cannabis retail, cannabis operations, and investments.
3. Innovative Industrial Properties, Inc. (NYSE:IIPR)
Number of Hedge Fund Holders: 18
On March 13, 2026, Innovative Industrial Properties, Inc. (NYSE:IIPR) reported that the board announced a first-quarter dividend of $1.90 per share, representing an annualized $7.60 per share, payable on April 15 to stockholders of record on March 31. The corporation also announced a quarterly dividend of $0.5625 per share for its 9.00% Series. A preferred stock, with $1.1 billion in common stock dividends paid since its inception.
Innovative Industrial Properties, Inc. announced full-year 2025 results, achieving sales of $266.0 million and net income of $114.4 million, or $3.93 per diluted share, while producing AFFO of $205.4 million, or $7.24 per share. Executive Chairman Alan Gold stated that the firm advanced portfolio diversification and balance sheet strength by raising $146 million in debt and preferred equity, signing new leases, and establishing a $100 million revolving credit facility.
Innovative Industrial Properties, Inc. is a real estate investment trust that focuses on the acquisition, ownership, and management of industrial buildings. It works in two segments: Cannabis Portfolio and Life Science Portfolio.
2. The Scotts Miracle-Gro Company (NYSE:SMG)
Number of Hedge Fund Holders: 33
On March 26, 2026, JPMorgan reduced The Scotts Miracle-Gro Company (NYSE:SMG) to Neutral from Overweight, lowering its price objective to $67 from $70. The corporation noted rising input costs, predicting higher prices for urea, diesel, and high-density polyethylene due to the Iran conflict. JPMorgan said that these market conditions may cause raw material costs to rise in fiscal 2027 compared to 2026, raising uncertainty about earnings growth.
The Scotts Miracle-Gro Company released fiscal first-quarter 2026 results, with U.S. Consumer net sales of $328.5 million, a GAAP gross margin of 25.0%, and adjusted EBITDA of $3.0 million, up $2.1 million year on year. The corporation stated plans to divest its Hawthorne subsidiary and approved a $500 million share repurchase program beginning in late 2026. CEO Jim Hagedorn noted that the divestment will increase margins. CFO Mark Scheiwer stated that performance is consistent with fiscal 2026 guidance, which includes adjusted EPS ranging from $4.15 to $4.35.
The Scotts Miracle-Gro Company manufactures, markets, and sells lawn and garden care products, as well as indoor and hydroponic growing solutions. The company’s products and services include lawn care, gardening and landscaping, hydroponic hardware and growing environments, lighting, controls, and marketing agreements.
1. Turning Point Brands, Inc. (NYSE:TPB)
Number of Hedge Fund Holders: 45
Alliance Global analyst Aaron Grey boosted Turning Point Brands, Inc. (NYSE:TPB )’s price objective to $135 from $110 on March 3, 2026, while keeping a Buy rating following the company’s fourth-quarter results. The analyst said that higher trade spending adds some volatility in net sales guidance. However, he anticipates significant sales growth in 2026, adding that the corporation might emerge as a leader in the modern oral pouch segment.
On March 2, 2026, Turning Point Brands, Inc. published fourth-quarter and full-year 2025 results, with Q4 net sales of $121.0 million, up 29.2% year on year, net income of $8.2 million, up 239.8%, and adjusted EBITDA of $30.0 million, climbing by 14.4%. The firm reported full-year net sales of $463.1 million, a 28.4% rise, with net income of $58.2 million and adjusted EBITDA of $119.5 million. CEO Graham Purdy pointed out that modern oral products fueled growth, with Q4 sales up 266% to $41.3 million.
Turning Point Brands, Inc. manufactures, markets, and distributes branded consumer items, including alternative smoking accessories and consumables containing active substances. It functions through three segments: Zig-Zag Products, Stoker’s Products, and Creative Distribution Solutions.
READ NEXT: 20 Best Performing Stocks in 2025 and 12 Best Food Stocks to Buy in 2026.
Hedge Fund Resource Center